protosappanin a has been researched along with celastrol in 1 studies
| Studies (protosappanin a) | Trials (protosappanin a) | Recent Studies (post-2010) (protosappanin a) | Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) |
|---|---|---|---|---|---|
| 22 | 0 | 14 | 885 | 1 | 741 |
| Protein | Taxonomy | protosappanin a (IC50) | celastrol (IC50) |
|---|---|---|---|
| Telomerase reverse transcriptase | Homo sapiens (human) | 0.78 | |
| Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Homo sapiens (human) | 6.8 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 8.41 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L3 | Homo sapiens (human) | 6.8 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.45 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 3.1 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 3.5667 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.25 | |
| Regulator of G-protein signaling 17 | Homo sapiens (human) | 6.1795 | |
| Ubiquitin carboxyl-terminal hydrolase 15 | Homo sapiens (human) | 6.8 | |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Homo sapiens (human) | 6.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuong, TD; Hung, TM; Min, BK; Min, BS; Shin, BS; Woo, MH | 1 |
1 other study(ies) available for protosappanin a and celastrol
| Article | Year |
|---|---|
Compounds from the heartwood of Caesalpinia sappan and their anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Benzopyrans; Caesalpinia; Cell Line; Chromans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Lipopolysaccharides; Macrophages; Mice; Molecular Conformation; Nitric Oxide; Nitric Oxide Synthase Type II; RNA, Messenger; Structure-Activity Relationship | 2012 |